Whole exome sequencing analysis of the neoadjuvant bevacizumab plus pemetrexed and carboplatin for unresectable stage III lung adenocarcinoma: Results of the phase II GASTO 1001 trial.

2016 
e20045Background: GASTO 1001 is a phase II trial investigating the efficacy and safety of induction bevacizumab plus chemotherapy followed by surgery in unresectable stage III lung adenocarcinoma. ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []